Stock LMAT LEMAITRE VASCULAR, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News LeMaitre Vascular, Inc.

Equities

LMAT

US5255582018

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
78.88 USD +0.14% Intraday chart for LeMaitre Vascular, Inc. -1.09% +38.97%
May. 31 Roth MKM Upgrades LeMaitre Vascular to Buy Rating With $100 Price Target MT
May. 10 Tranche Update on LeMaitre Vascular, Inc.'s Equity Buyback Plan announced on February 27, 2024. CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Roth MKM Upgrades LeMaitre Vascular to Buy Rating With $100 Price Target
MT
LeMaitre to Present at the Jefferies Global Healthcare Conference
AQ
Ex-dividend day
FA
Tranche Update on LeMaitre Vascular, Inc.'s Equity Buyback Plan announced on February 27, 2024.
CI
Tranche Update on LeMaitre Vascular, Inc.'s Equity Buyback Plan announced on February 23, 2023.
CI
Lemaitre Vascular Insider Sold Shares Worth $9,314,501, According to a Recent SEC Filing
MT
Lemaitre Vascular Insider Sold Shares Worth $379,991, According to a Recent SEC Filing
MT
Barrington Boosts Price Target on LeMaitre Vascular to $79 From $69, Keeps Outperform Rating
MT
LeMaitre: Q1 Earnings Snapshot
AQ
Transcript : LeMaitre Vascular, Inc., Q1 2024 Earnings Call, May 02, 2024
Earnings Flash (LMAT) LEMAITRE VASCULAR Posts Q1 Revenue $53.5M, vs. Street Est of $51.5M
MT
(LMAT) LEMAITRE VASCULAR Sees Fiscal Year 2024 EPS $1.79
MT
(LMAT) LEMAITRE VASCULAR Expects Q2 EPS $0.47
MT
(LMAT) LEMAITRE VASCULAR Forecasts Q2 Revenue $50.1M
MT
LeMaitre Q1 2024 Financial Results
AQ
LeMaitre Vascular, Inc. Provides Earnings Guidance for the Second Quarter and Full Year 2024
CI
LeMaitre Vascular, Inc. Approves Quarterly Cash Dividend, Payable on May 30, 2024
CI
LeMaitre Vascular, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
North American Morning Briefing : Investors Brace -2-
DJ
Stifel Upgrades LeMaitre Vascular to Buy From Hold, Adjusts Price Target to $75 From $59
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LMAT Stock
  4. News LeMaitre Vascular, Inc.